Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-09-25

FDA Approved: FLUOXETINE — Supplemental Application (QUALLENT PHARMACEUTICALS HEALTH LLC)

View source ↗

Summary

FDA approved a supplemental application for Fluoxetine hydrochloride from Quallent Pharmaceuticals Health LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluoxetine (Fluoxetine)

Snippet

SUPPL AP for FLUOXETINE (FLUOXETINE HYDROCHLORIDE)